Iris Manzano

Mrs. Iris Manzano

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Gene
Verified
Journal Article
Closed access
Ricardo Usategui-MartínRicardo Usategui-Martín
Ricardo Usategui-Martín
JPJose-Luis Pérez-Castrillón
Jose-Luis Pérez-Castrillón
MMMaría L. Mansego
María L. Mansego
FLFrancisco Lara-Hernández
Francisco Lara-Hernández
IMIris Manzano
Iris Manzano
FCFELIPE JAVIER CHAVES
FELIPE JAVIER CHAVES

23 June 2023 in Biology
Verified
Journal Article
Open access
PDF file
SGSoraya García-Sorribes
Soraya García-Sorribes
FHFrancisco Lara Hernández
Francisco Lara Hernández
IMIris Manzano
Iris Manzano
JAJessica Abadía-Otero
Jessica Abadía-Otero
EAEliseo Albert
Eliseo Albert
FCFELIPE JAVIER CHAVES
FELIPE JAVIER CHAVES
The SARS-CoV-2 coronavirus is responsible for the COVID-19 pandemic resulting in a global health emergency. Given its rapid spread and high number of infected individuals, a diagnostic tool for a rapid, simple, and cost-effective detection was essential. In this work, we developed a COVID-19 diagnostic test, that incorporates a human internal control, based on the Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP). When working with synthetic SARS-CoV-2 RNA, the optimized RT-LAMP assay has a sensitivity of 10 viral copies and can be detected by fluorescence in less than 15 min or by the naked eye in 25 min using colorimetric RT-LAMP. To avoid the RNA extraction step, a pre-treatment of the sample was optimized. Subsequently, a validation was performed on 268 trypsin treated samples (including nasopharyngeal, buccal, and nasal exudates) and amplified with colorimetric RT-LAMP to evaluate its sensitivity and specificity in comparison with RT-qPCR of extracted samples. The validation results showed a sensitivity and specificity of 100% for samples with Ct ≤ 30. The rapid, simple, and inexpensive RT-LAMP SARS-CoV-2 extraction-free procedure developed may be an alternative test that could be applied for the detection of SARS-CoV-2 or adapted to detect other viruses present in saliva or nasopharyngeal samples with higher sensitivity and specificity of the antibody test.